In addition to these, the investigation of further upstream regulators of the TGF-β, IFN-α/β, and NRF2 or other pathways involved in inflammation, specifically concerning microglia and astrocytes, is still necessary to detect possible targets for curative epilepsy treatment. The gene discussed is NFE2L2; the disease is epilepsy.